SCHEMBL4030167

SCHEMBL4030167

COC(=O)c1nc(-c2sccc2N)n(C)c(=O)c1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 3/20 0.46
FEN1 P39748 3/20 0.46
ERCC4 Q92889 3/20 0.46
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 1/20 0.36
RNASEH1 O60930 1/20 0.36
PKM P14618 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6436946 0.86 FEN1 (0.62) ERCC1FEN1ERCC4RNASEH1
Hydrochloric Acid SCHEMBL4031283 0.85 FEN1 (0.60) ERCC1FEN1ERCC4RNASEH1
SCHEMBL4028309 0.84 ALDH1A1 (0.34) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4029963 0.84 ERCC1 (0.45) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4032112 0.83 ALDH1A1 (0.34) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4028581 0.83 ERCC1 (0.44) ERCC1FEN1ERCC4ALDH1A1RNASEH1
SCHEMBL4028095 0.82 GABRP (0.32) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4028040 0.79 ERCC1 (0.45) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL6450711 0.79 ERCC1 (0.45) ERCC1FEN1ERCC4KDM4EALDH1A1
SCHEMBL4028038 0.79 ERCC1 (0.45) ERCC1FEN1ERCC4KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP disclosed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors POLR2A, POLR1E, POLR2E ERCC1 3181/4885FEN1 343/4885ERCC4 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.